BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Stemline Therapeutics, Inc. 

1675 York Avenue
Suite 30-E
New York  New York  10128  U.S.A.
Phone: 212-831-1111 Fax:


SEARCH JOBS










 Company News
Stemline Therapeutics, Inc. (STML) Announces Proposed Public Offering Of Common Stock 1/8/2015 7:54:20 AM
Stemline Therapeutics, Inc. (STML) In-Licenses Novel Oral Small Molecule Nuclear Transport Inhibitor Targeting XPO1 1/8/2015 7:53:23 AM
Stemline Therapeutics, Inc. (STML) Prices $59.85 Million Public Offering Of Common Stock 1/8/2015 7:44:33 AM
Stemline Therapeutics, Inc. (STML) To Present At The 33rd Annual J.P. Morgan Healthcare Conference 12/29/2014 7:24:07 AM
Stemline Therapeutics, Inc. (STML) Initiates SL-401 Clinical Trial In Four Rare Myeloproliferative Neoplasms 12/17/2014 7:29:19 AM
Stemline Therapeutics, Inc. (STML) Announces Multiple Preclinical Presentations Highlighting Its Pipeline Of IL-3R-Directed Therapeutics At The American Society of Hematology Annual Meeting 12/5/2014 12:15:21 PM
Stemline Therapeutics, Inc. (STML) Reports Third Quarter 2014 Financial Results And Provides Corporate Update 11/12/2014 8:03:28 AM
Stemline Therapeutics, Inc. (STML) To Participate In The Barclays Select Series Symposium 11/10/2014 10:14:09 AM
Stemline Therapeutics, Inc. (STML) Initiates SL-401 Trial In AML Patients In First Complete Response With Minimal Residual Disease, The Second SL-401 Trial Initiated In 2H14 10/16/2014 7:38:20 AM
Stemline Therapeutics, Inc. (STML) To Present At The Aegis Capital 2014 Healthcare & Technology Conference 9/8/2014 7:55:56 AM
12345678